XIAP and neoplasm: Because XIAP overexpression correlates strongly with cancer progression and chemoresistance, small-molecule XIAP antagonists [30–32] and SMAC mimetics [33–35] have been developed to inhibit the interaction between XIAP and these caspases to kill malignant tumor cells.